{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T10:18:51Z","timestamp":1780654731135,"version":"3.54.1"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.thromres.2023.04.002","type":"journal-article","created":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T02:08:56Z","timestamp":1681178936000},"page":"56-60","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Early immune tolerance induction is a unique predictor of favorable outcomes in hemophilia A children with intron 22 inversion and high-responding inhibitors"],"prefix":"10.1016","volume":"226","author":[{"given":"Jie","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zekun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoqing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanru","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingzi","family":"Zhen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runhui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.thromres.2023.04.002_bb0005","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1177\/1076029616687848","article-title":"Spectrum of molecular defects in 216 chinese families with hemophilia a: identification of noninversion mutation hot spots and 42 novel mutations","volume":"24","author":"Guo","year":"2018","journal-title":"Clin. Appl. Thromb. Hemost."},{"issue":"5","key":"10.1016\/j.thromres.2023.04.002_bb0010","doi-asserted-by":"crossref","first-page":"e328","DOI":"10.1111\/hae.13531","article-title":"The japanese immune tolerance induction (J-ITI) study in haemophilia patients with inhibitor: outcomes and successful predictors of ITI treatment","volume":"24","author":"Nogami","year":"2018","journal-title":"Haemophilia"},{"issue":"11","key":"10.1016\/j.thromres.2023.04.002_bb0015","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1111\/j.1538-7836.2009.03615.x","article-title":"Factor VIII gene (F8) mutations as predictors of outcome in immune tolerance induction of hemophilia a patients with high-responding inhibitors","volume":"7","author":"Coppola","year":"2009","journal-title":"J. Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.thromres.2023.04.002_bb0020","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/hae.14431","article-title":"Predictors of inhibitor eradication by primary immune tolerance induction in severe haemophilia a with high responding inhibitors","volume":"28","author":"Di Minno","year":"2022","journal-title":"Haemophilia"},{"issue":"3","key":"10.1016\/j.thromres.2023.04.002_bb0025","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/hae.12608","article-title":"Prompt immune tolerance induction at inhibitor diagnosis regardless of titre may increase overall success in haemophilia a complicated by inhibitors: experience of two U.S. Centres","volume":"21","author":"Nakar","year":"2015","journal-title":"Haemophilia"},{"issue":"5","key":"10.1016\/j.thromres.2023.04.002_bb0030","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.transci.2019.08.008","article-title":"Hemophilia a with inhibitor: immune tolerance induction (ITI) in the mirror of time","volume":"58","author":"Nakar","year":"2019","journal-title":"Transfus. Apher. Sci."},{"key":"10.1016\/j.thromres.2023.04.002_bb0035","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.thromres.2018.05.027","article-title":"Risk factors for inhibitor development in severe hemophilia A","volume":"168","author":"Garagiola","year":"2018","journal-title":"Thromb. Res."},{"issue":"12","key":"10.1016\/j.thromres.2023.04.002_bb0040","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1182\/blood-2011-09-379453","article-title":"F8 gene mutation type and inhibitor development in patients with severe hemophilia a: systematic review and meta-analysis","volume":"119","author":"Gouw","year":"2012","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.thromres.2023.04.002_bb0045","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/j.1365-2516.2012.02909.x","article-title":"Guidelines for the management of hemophilia","volume":"19","author":"Srivastava","year":"2013","journal-title":"Haemophilia"},{"issue":"2","key":"10.1016\/j.thromres.2023.04.002_bb0050","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1055\/s-0038-1653759","article-title":"The Nijmegen modification of the Bethesda assay for factor VIII: C inhibitors: improved specificity and reliability","volume":"73","author":"Verbruggen","year":"1995","journal-title":"Thromb. Haemost."},{"issue":"6","key":"10.1016\/j.thromres.2023.04.002_bb0055","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1182\/blood-2011-08-369132","article-title":"International immune tolerance study. The principal results of the international immune tolerance study: a randomized dose comparison","volume":"119","author":"Hay","year":"2012","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.thromres.2023.04.002_bb0060","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.blre.2018.02.003","article-title":"Review of immune tolerance induction in hemophilia A","volume":"32","author":"Schep","year":"2018","journal-title":"Blood Rev."},{"issue":"11","key":"10.1016\/j.thromres.2023.04.002_bb0065","first-page":"1186","article-title":"Immune tolerance study group (ITSG). Immune tolerance in hemophilia with factor VIII inhibitors: predictors of success","volume":"86","author":"Mariani","year":"2001","journal-title":"Haematologica"},{"issue":"Suppl 1","key":"10.1016\/j.thromres.2023.04.002_bb0070","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1423-0410.1999.tb00011.x","article-title":"Comparison of the international immune tolerance registry and the north american immune tolerance registry","volume":"77","author":"Kroner","year":"1999","journal-title":"Vox Sang."},{"issue":"3","key":"10.1016\/j.thromres.2023.04.002_bb0075","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/hae.12102","article-title":"Immune tolerance induction in haemophilia a patients with inhibitors by treatment with recombinant factor VIII: a retrospective non-interventional study","volume":"19","author":"Rivard","year":"2013","journal-title":"Haemophilia"},{"issue":"4","key":"10.1016\/j.thromres.2023.04.002_bb0080","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12723","article-title":"F8 gene mutation spectrum in severe hemophilia a with inhibitors: a large cohort data analysis from a single center in China","volume":"6","author":"Sun","year":"2022","journal-title":"Res. Pract. Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.thromres.2023.04.002_bb0085","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1365-2516.2008.01880.x","article-title":"The north american immune tolerance registry: contributions to the thirty-year experience with immune tolerance therapy","volume":"15","author":"Dimichele","year":"2009","journal-title":"Haemophilia"},{"issue":"5","key":"10.1016\/j.thromres.2023.04.002_bb0090","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/hae.12730","article-title":"US guidelines for immune tolerance induction in patients with haemophilia a and inhibitors","volume":"21","author":"Valentino","year":"2015","journal-title":"Haemophilia"},{"issue":"6","key":"10.1016\/j.thromres.2023.04.002_bb0095","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.immuni.2008.11.002","article-title":"Homeostasis of naive and memory T cells","volume":"29","author":"Surh","year":"2008","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.thromres.2023.04.002_bb0100","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1096\/fj.11-193672","article-title":"Naturally occurring regulatory T cells: markers, mechanisms, and manipulation","volume":"26","author":"Schmetterer","year":"2012","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.thromres.2023.04.002_bb0105","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/imr.12011","article-title":"The establishment of the plasma cell survival niche in the bone marrow","volume":"251","author":"Chu","year":"2013","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.thromres.2023.04.002_bb0110","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1046\/j.1600-065X.2003.00079.x","article-title":"Dendritic cells: regulators of alloimmunity and opportunities for tolerance induction","volume":"196","author":"Morelli","year":"2003","journal-title":"Immunol. Rev."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384823000944?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384823000944?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:50:41Z","timestamp":1758736241000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384823000944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":22,"alternative-id":["S0049384823000944"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2023.04.002","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early immune tolerance induction is a unique predictor of favorable outcomes in hemophilia A children with intron 22 inversion and high-responding inhibitors","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2023.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}